StonvexLoading…
StonvexStonvexStonvexCore line items from STSS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $192.78K | $204.12K | $306.34K | $222.72K |
Operating Income | $-86.27M | $-269.74M | $-107.67M | $-5.03M |
Net Income | $-86.24M | $-282.50M | $-99.85M | $3.56M |
EPS (Diluted) | $-1.19 | $-11.16 | $-11.79 | $10.45 |
Total Assets | $181.00M | $269.08M | $443.96M | $17.09M |
Total Liabilities | $2.22M | $4.70M | $10.75M | $2.55M |
Cash & Equivalents | $12.32M | $10.38M | $10.52M | $8.32M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-15.15M | $-6.32M |
Shares Outstanding | 39.42M | 29.00M | 27.63M | 1.02M |